Can extracellular vesicles be considered as a potential frontier in the treatment of intervertebral disc disease? DOI Creative Commons
S.Y. Zhu, Junlin Wang,

Moran Suo

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 92, С. 102094 - 102094

Опубликована: Окт. 18, 2023

As a global public health problem, low back pain (LBP) caused by intervertebral disc degeneration (IDD) seriously affects patients' quality of life. In addition, the prevalence IDD tends to be younger, which brings huge burden individuals and society economically. Current treatments do not delay or reverse progression IDD. The emergence biologic therapies has brought new hope for treatment Among them, extracellular vesicles (EVs), as nanoscale bioactive substances that mediate cellular communication, have now produced many surprising results in research This article reviews mechanisms roles EVs delaying describes prospects challenges EVs.

Язык: Английский

Bone aging and extracellular vesicles DOI
Jian Wang, Yuanwei Zhang, Sicheng Wang

и другие.

Science Bulletin, Год журнала: 2024, Номер unknown

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

3

Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration DOI Creative Commons
Zhichao Li, Yan Wu,

Guoqing Tan

и другие.

Frontiers in Pharmacology, Год журнала: 2022, Номер 13

Опубликована: Сен. 8, 2022

Low back pain has been found as a major cause of global disease burden and disability. Intervertebral disc degeneration is recognized the vital factor causing low pain. complex mechanism cannot be avoided. Traditional strategies for treatment intervertebral meet needs regeneration, so novel methods are urgently required. Exosomes refer to extracellular vesicles that can released by most cells, play roles in intercellular material transport information transmission. MicroRNAs have identified essential components exosomes, which selectively ingested exosomes delivered receptor cells regulation physiological activities functions cells. Existing studies progressively focused on role exosomal microRNAs degeneration. The focus this paper placed changes microenvironment during biogenesis action microRNAs. research results deficiencies apoptosis, matrix homeostasis, inflammatory response, oxidative stress, angiogenesis primarily investigated. aim identify latest results, potential applications challenges emerging strategy.

Язык: Английский

Процитировано

15

The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology DOI Creative Commons
Xiaoyang Liu, Zongke Zhou, Wei‐Nan Zeng

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2023, Номер 11

Опубликована: Окт. 23, 2023

Osteoimmunology is a concept involving molecular and cellular crosstalk between the skeletal immune systems. Toll-like receptors (TLRs) are widely expressed both on mesenchymal stromal cells (MSCs), hematopoietic cells, in osteogenic microenvironment for bone development or repair. TLRs can sense exogenous pathogen-associated patterns (PAMPs) derived from microorganisms, damage-associated (DAMPs) normal subjected to injury, inflammation, cell apoptosis under physiological pathological conditions. Emerging studies reported that TLR signaling plays an important role remodeling by directly impacting MSC differentiation osteoimmunology. However, how regulate critical remains be elucidated promote of MSCs new formation tissue This review outlines distinct variants various tissues, detailing impact pathway activation inhibition differentiation. It also elucidates pathways’ interplay with osteoclasts, extracellular vesicles (EVs) MSCs. Furthermore, we explore biomaterial-based guide MSCs’ Therefore, understanding TLRs’ this context has significant implications advancing regeneration repair strategies.

Язык: Английский

Процитировано

8

Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway DOI

Yuzhu Xu,

Fan Pan, Lei Liu

и другие.

Journal of Zhejiang University SCIENCE B, Год журнала: 2023, Номер 24(2), С. 115 - 129

Опубликована: Фев. 1, 2023

Язык: Английский

Процитировано

7

Can extracellular vesicles be considered as a potential frontier in the treatment of intervertebral disc disease? DOI Creative Commons
S.Y. Zhu, Junlin Wang,

Moran Suo

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 92, С. 102094 - 102094

Опубликована: Окт. 18, 2023

As a global public health problem, low back pain (LBP) caused by intervertebral disc degeneration (IDD) seriously affects patients' quality of life. In addition, the prevalence IDD tends to be younger, which brings huge burden individuals and society economically. Current treatments do not delay or reverse progression IDD. The emergence biologic therapies has brought new hope for treatment Among them, extracellular vesicles (EVs), as nanoscale bioactive substances that mediate cellular communication, have now produced many surprising results in research This article reviews mechanisms roles EVs delaying describes prospects challenges EVs.

Язык: Английский

Процитировано

7